Skip to Content

Quantbot Technologies LP invests $146,000 in Doximity, Inc. (NASDAQ:DOCS)

Quantbot Technologies LP invests $146,000 in Doximity, Inc. (NASDAQ:DOCS)

According to the most recent SEC filing that the company has made, Quantbot Technologies LP increased its stake in Doximity, INC (NASDAQ: DOCS) shares during the third quarter of 2018.

The institutional investor spent close to $146,000 to purchase 4,857 shares of the company’s stock.

This brings the total number of dollars spent to approximately $146,000.

Several additional large investors have recently changed their financial position regarding the company’s stock.

In the third quarter, Polen Capital Management LLC made a 65.9% increase in the amount of Doximity stock it owned, bringing its total percentage ownership to 100%.

After purchasing 84,133 additional shares during the most recent fiscal quarter, Polen Capital Management LLC now owns a total of 211,853 shares, which have a value of $6,402,000.

These shares were acquired, bringing the total number of shares owned by the company to 211,853.

During the third quarter, BP PLC achieved a 39.6% increase in the proportion of Doximity it owned.

BP PLC now has 92,481 shares after purchasing an additional 26,254 in the most recent quarter.

Each share of the company is currently worth approximately $2,795,000.

A. Julius Bar & Co Zurich increased the percentage of ownership it held in Doximity by 78.1% during the third quarter.

Bank Julius Baer and Co Zurich now own 9,025 shares of the company’s stock, which are worth a total of $273,000 after the company purchased 3,958 shares during the most recent quarter.

During the third quarter, Russell Investments Group Ltd made a 477.3% increase in the proportion of its holdings allocated to Doximity.

After making additional purchases totaling 138,532 shares during the most recent fiscal quarter, Russell Investments Group Ltd now possesses 167,557 shares.

These 167,557 shares of the company’s stock are worth a total of $5,084,000 to the investor.

During the third quarter of this year, First Republic Investment Management INC saw an increase of 82.7 percentage points in the value of their investment in Doximity. First Republic Investment Management INC now has 13,312 shares, valued at $402,000, after purchasing an additional 6,027 shares during the most recent quarter.

The company purchased these shares. 52.48 institutional investors and hedge funds own a percent of the company’s outstanding shares.
When trading started on Tuesday, the price of one share of DOCS stock was $37.40 per share.

Doximity, INC hit a low point over the past 52 weeks of $22.91, while the company reached a high point over the past 52 weeks of $64.95.

The price-to-earnings ratio for the stock is 57.54; the price-to-growth ratio is 19.89, and the stock’s beta value is 0.87.

The stock’s market capitalization is $7.20 billion.

The stock price has a moving average of $34.08 over the past 50 days, while its moving average over the past 200 days is $32.81.

Doximity’s most recent quarterly earnings report, released on November 10 and denoted by the ticker symbol NASDAQ: DOCS, can be found here. For the period under consideration, the company reported an earnings per share (EPS) amount of $0.12, which was in line with the consensus estimate of $0.12 reached among market experts.

Doximity had a return on equity of 16.41%, and its net margin was 36.70%.

The company’s overall profitability was excellent.

The company’s sales for the quarter came in at $102.1 million, which is a significant increase compared to the industry analysts’ forecast of $99.86 million for the company’s sales for the quarter.

During the current fiscal year, it is anticipated that Doximity, INC will generate profits per share amounting to $0.52.

These projections are based on estimates provided by sell-side analysts.

Recent reports on the stock that several research analysts have been following closely have been produced.

Piper Sandler stated their intention to reduce their price target on Doximity shares from $39.00 to $35.00 in a research note that was published on Friday, November 11.

Piper Sandler’s announcement was made public.

The price target that Wells Fargo & Company has set for Doximity shares has increased from $38.00 to $44.00, as stated in a research note published on Friday, November 11.

Additionally, the company gave the stock a rating of “overweight,” indicating that it is expected to perform well. On Friday, January 6, Morgan Stanley released a research note stating that they had downgraded Doximity from “equal weight” to “underweight” and that they had decreased their price objective from $32 to $29.00.

The note also stated that they had decreased their price objective from $32 to $29. On Thursday, October 13, BTIG Research issued a research note in which they mentioned that they would be expanding their research coverage to include proximity shares.

They assigned a ” neutral ” rating to the stock for their investment portfolio.

In a research note released on Friday, November 11, Evercore ISI announced they were increasing their price target for Doximity shares from $28.00 to $32.00.

Eight of the equity research experts have suggested purchasing the stock, three have suggested holding onto it, and two have suggested selling it.

Bloomberg reports that the current recommendation for the stock is “Hold” and that the $41.40 price target analysts have set for the stock is also reported to be the consensus price goal.

On Thursday, February 2, Doximity’s Chief Financial Officer, Anna Bryson, sold 25,000 shares of the company’s stock after exercising her option to do so.

This was another piece of news concerning the company.

An overall price of one million dollars was agreed upon for the sale of the shares, which works out to an average price of forty dollars per share bought and sold.

The chief financial officer now has a direct ownership stake in 104,763 company shares, which have a value of $4,190,520 as a direct result of the transaction. You will be taken to a legal file submitted to the SEC if you click on the link we have provided, where you will find additional information regarding the sale.

The insiders collectively own 45.21 percent of the company’s shares.

The digital platform managed by Doximity, INC is hosted in the cloud and is designed for use by medical professionals in the United States. Users of the platform offered by the company have access to applications designed with the requirements of medical professionals in mind.

These tools allow users to work together on patient care plans, manage their careers, stay current on the most recent medical research and news developments, and conduct virtual patient visits.


Leave a comment

Your email address will not be published. Required fields are marked *